BEBETTER MED INC. — Investor Relations & Filings
About BEBETTER MED INC.
BEBETTER MED INC. is a clinical-stage company dedicated to the discovery and development of innovative small molecule therapeutics. The organization focuses on addressing unmet medical needs within the fields of oncology, metabolic disorders, and autoimmune diseases. Its research and development pipeline features a range of proprietary drug candidates, with a particular emphasis on targeted therapies and kinase inhibitors. By leveraging advanced drug discovery platforms, the company identifies and optimizes lead compounds to advance through clinical evaluation. BEBETTER MED INC. oversees the entire development lifecycle, including preclinical research, clinical trial management, and the pursuit of regulatory approvals for its therapeutic candidates.
Recent filings
| Filing | Released | Lang | Actions |
|---|---|---|---|
| 广州必贝特医药股份有限公司2025年年度业绩预亏公告 | 2026-01-23 | Chinese | |
| 广州必贝特医药股份有限公司股票交易异常波动公告 | 2026-01-07 | Chinese | |
| 湖南启元律师事务所关于广州必贝特医药股份有限公司2025年第一次临时股东大会的法律意见书 | 2025-11-28 | Chinese | |
| 2025年第一次临时股东大会决议公告 | 2025-11-28 | Chinese | |
| 关于开立募集资金现金管理专用结算账户的公告 | 2025-11-26 | Chinese | |
| 广州必贝特医药股份有限公司2025年第一次临时股东大会会议资料 | 2025-11-21 | Chinese |
| ID | Filing | Released | Lang | Actions | |
|---|---|---|---|---|---|
|
2026
2 filings
| |||||
| 39585536 | 广州必贝特医药股份有限公司2025年年度业绩预亏公告 | 2026-01-23 | Chinese | ||
| 39585529 | 广州必贝特医药股份有限公司股票交易异常波动公告 | 2026-01-07 | Chinese | ||
|
2025
13 filings
| |||||
| 39585521 | 湖南启元律师事务所关于广州必贝特医药股份有限公司2025年第一次临时股东大会的法律意见书 | 2025-11-28 | Chinese | ||
| 39585505 | 2025年第一次临时股东大会决议公告 | 2025-11-28 | Chinese | ||
| 39585502 | 关于开立募集资金现金管理专用结算账户的公告 | 2025-11-26 | Chinese | ||
| 39585496 | 广州必贝特医药股份有限公司2025年第一次临时股东大会会议资料 | 2025-11-21 | Chinese | ||
| 39585488 | 广州必贝特医药股份有限公司对外担保管理制度 | 2025-11-12 | Chinese | ||
| 39585479 | 广州必贝特医药股份有限公司防范控股股东及关联方资金占用管理制度 | 2025-11-12 | Chinese | ||
| 39585472 | 广州必贝特医药股份有限公司对外投资管理制度 | 2025-11-12 | Chinese | ||
| 39585463 | 广州必贝特医药股份有限公司股东会议事规则 | 2025-11-12 | Chinese | ||
| 39585459 | 广州必贝特医药股份有限公司信息披露管理办法 | 2025-11-12 | Chinese | ||
| 39585452 | 关于召开2025年第一次临时股东大会的通知 | 2025-11-12 | Chinese | ||
| 39585444 | 关于变更公司注册资本、公司类型、修订《公司章程》并办理工商变更登记的公告 | 2025-11-12 | Chinese | ||
| 39585440 | 广州必贝特医药股份有限公司募集资金使用管理制度 | 2025-11-12 | Chinese | ||
| 39585436 | 广州必贝特医药股份有限公司关联交易管理制度 | 2025-11-12 | Chinese | ||
Market data
Market data not available
Price history
Peer group · Research and experimental development on natural sciences and engineering
| Company | Ticker | Country | Sector |
|---|---|---|---|
|
1NKEMIA
Biotechnology company providing R&D and services for the li…
|
IKM | ES | Professional, scientific and te… |
|
2cureX AB
Develops an IVD test using 3D tumoroids to predict patient …
|
2CUREX | SE | Professional, scientific and te… |
|
Abattis Bioceuticals Corp.
Life sciences company aggregating and investing in cannabis…
|
ATTBF | CA | Professional, scientific and te… |
|
Abera Bioscience AB
Develops mucosal vaccines using a proprietary Outer Membran…
|
ABERA | SE | Professional, scientific and te… |
|
ABION Inc.
Clinical-stage biopharma developing therapeutics for oncolo…
|
203400 | KR | Professional, scientific and te… |
|
ABL Bio Inc.
Develops bispecific antibody therapeutics for oncology and …
|
298380 | KR | Professional, scientific and te… |
|
Abnova (Taiwan) Corporation
Global leader in high-throughput production of antibodies a…
|
4133 | TW | Professional, scientific and te… |
|
Abpro Holdings, Inc.
Clinical-stage biotech developing antibody therapeutics for…
|
ABP | US | Professional, scientific and te… |
|
Absci Corp
A generative AI drug creation company developing biologic m…
|
ABSI | US | Professional, scientific and te… |
|
Achiko AG
A digital services platform for cross-border business compl…
|
ACHI | CH | Professional, scientific and te… |
BEBETTER MED INC. via the API
Pull this company's filings, identifiers, and metadata as JSON or Markdown. Authenticate with your API key, then query by company ID, ISIN, or LEI. Full schema documented in the OpenAPI spec.
Endpoints
| GET | /api/companies/58625/ | Company identity, sector, listing, identifiers |
| GET | /api/filings/?company=58625 | Paginated list of all filings (filterable by type, date, language) |
| GET | /api/filings/{id}/ | Single filing — metadata, document URL, processing status |
| GET | /api/filings/{id}/markdown/ | Filing content as Markdown (PDF → text/tables/figures) |
| GET | /api/isins/?company=58625 | All ISINs registered to this company |
| GET | /api/filing-types/ | Reference: every filing-type code + category |
cURL
$ curl https://api.financialreports.eu/api/filings/?company=58625 \ -H "x-api-key: $FR_API_KEY" \ -H "Accept: application/json"
Python
import requests r = requests.get( "https://api.financialreports.eu/api/filings/", params={"company": 58625}, headers={"x-api-key": API_KEY}, ) filings = r.json()["results"]
MCP server
// MCP server URL https://mcp.financialfilings.com/mcp // Once connected, the LLM can query this company directly: "Pull the latest 5 filings for BEBETTER MED INC. (id: 58625)"
Report missing filing
Can't find a specific document? Let us know and we'll add it within 24 hours.